About Us
Company
47266 Benicia Street
Fremont, CA 94538-7330
United States
Telephone: 510-354-0300
Toll Free: 888-354-0300
Biographies
Board of Director Biographies
Mr.Tony Shum
Mr. Shum is a Business Development executive for the global banking group HSBC. Mr. Shum is a Chartered Accountant and has worked for Deloitte & Touché in Canada and Price Waterhouse in Hong Kong. Upon leaving public practice, Mr. Shum joined Walt Disney Television International where he helped to establish its broadcast television business in the Asia-Pacific region. He has also worked for a private equity venture capital investment firm and has provided business strategy and analysis services in Asia Pacific and Europe for businesses ranging from start-up ventures to multi-national corporations.
Mr. Gabriel B. Vegh
Mr. Vegh has been one of our Directors since November 1992, and served as our CEO from 2001 to 2007 and as a President from June 2000 to May 2001. He was our Executive Vice President from January 1995 until June 2000, and our Chief Operating Officer from November 1994 through January 1995. Mr. Vegh was our President from May 1993 through November 1994, and our Chief Financial Officer from May 1993 through July 1996. Prior to Cardima, from August 1985 until May 1993, Mr. Vegh was the Vice President, Operations of Target Therapeutics, Inc., which is now a division of Boston Scientific Corporation. From February 1983 until August 1985, Mr. Vegh was General Manager, Pilot Operations of Advanced Cardiovascular Systems, Inc., which is now a division of Guidant Corporation. Mr. Vegh received a B.S. in Mechanical Engineering from the New Jersey Institute of Technology.
Dr. Phillip C. Radlick
Dr. Radlick has been one of our directors since November 1994. Dr. Radlick is currently and independent consultant in the healthcare industry. Dr. Radlick served as President and Chief Executive Officer of Lipid Sciences, Inc., a publicly held biotechnology company, from June 2000 until October 2002. Dr. Radlick was our President and Chief Executive Officer from November 1994 to June 2000. Prior to joining us, from November 1992 until October 1994, Dr. Radlick was the President and Chief Executive Officer of Hepatix, Inc., a start-up medical device company. From November 1986 until November 1992, Dr. Radlick was the President of Edward's Cardiovascular Surgery Division, a division of Baxter Healthcare responsible for the development, manufacture and sale of cardiovascular products. Dr. Radlick received a B.S. in Chemistry and a Ph.D. in Organic Chemistry from the University of California, Los Angeles.
Eric Chan, Ph.D.
Dr. Chan was promoted to Chief Technology Officer and appointed to the Board of Directors effective October 5, 2007. Before that he has been our Vice President of Product Development since June 1998. Prior to joining us, from August 1991 to March 1993, Dr. Chan was the Director of Engineering and from April 1993 to May 1998, Vice President of Engineering at Arrhythmia Research Technology, Inc. where he coordinated and directed the development of computerized cardiac electrophysiology and catheter lab systems, digital Holter and high resolution ECG systems. Dr. Chan received his B.S.E.E. from Purdue University, his M.S.E. in Biomedical Engineering from the University of Texas at Austin, and his Ph.D. in Biomedical Engineering from the University of Texas at Austin. He has completed the Global BioExecutive Program at the Haas School of Business, University of California, Berkeley. He was elected a Fellow of the European Society of Cardiology and a Senior Member of the Institute of Electrical and Electronic Engineers in 2003.
Mr. Robert Cheney
Mr. Cheney was nominated as CEO on August 31st, 2007. Mr. Cheney is also a director and shareholder of Apix International Limited. Mr. Cheney was previously the Chairman and CEO of a Hong Kong based telecommunications and Internet Services Company. Prior to his business career Mr. Cheney was a corporate lawyer in private practice qualified in Hong Kong, Canada and Britain.
Executive Officer Biographies
Mr. Robert Cheney
Mr. Cheney was nominated as CEO on August 31st, 2007. Mr. Cheney is also a director and shareholder of Apix International Limited. Mr. Cheney was previously the Chairman and CEO of a Hong Kong based telecommunications and Internet Services Company. Prior to his business career Mr. Cheney was a corporate lawyer in private practice qualified in Hong Kong, Canada and Britain.
Eric Chan, Ph.D.
Dr. Chan was promoted to Chief Technology Officer and appointed to the Board of Directors effective October 5, 2007. Before that he has been our Vice President of Product Development since June 1998. Prior to joining us, from August 1991 to March 1993, Dr. Chan was the Director of Engineering and from April 1993 to May 1998, Vice President of Engineering at Arrhythmia Research Technology, Inc. where he coordinated and directed the development of computerized cardiac electrophysiology and catheter lab systems, digital Holter and high resolution ECG systems. Dr. Chan received his B.S.E.E. from Purdue University, his M.S.E. in Biomedical Engineering from the University of Texas at Austin, and his Ph.D. in Biomedical Engineering from the University of Texas at Austin. He has completed the Global BioExecutive Program at the Haas School of Business, University of California, Berkeley. He was elected a Fellow of the European Society of Cardiology and a Senior Member of the Institute of Electrical and Electronic Engineers in 2003.
Mr.Chris Mak
Mr. Mak was appointed as Chief Financial Officer and Corporate Secretary in August 31st, 2007.. From September 2003 until July 2005, Mr. Mak was the International Finance Manager of Thermawave, Inc., a process control metrology system manufacturer, which is now a division of KLA-Tencor Corporation. From May 1999 to August 2003, Mr. Mak was the Accounting Director of Sirenza Microdevices Inc., a supplier of radio frequency components. Prior to May 1999, Mr. Mak held senior management positions with two private companies. Mr. Mak received a B.S. in Finance and a M.B.A in Finance from the California State University, Hayward, which is now known as California State University, East Bay.